Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07308717) titled 'Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Memorial Sloan Kettering Cancer Center
Condition:
Breast Cancer
Intervention:
Other: Modification to Pre-operative Order Set
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: December 16, 2025
Target Sample Size: 1896
Countries of Recruitment:
United States
To know more, visit https://clinicalt...